The US Court of Appeals for the Federal Circuit affirmed a district court decision rejecting claims of a patent application directed to a dosing regimen for a cancer treatment, finding the claims to be obvious where the...more
3/13/2025
/ Appeals ,
Healthcare ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Inventors ,
Life Sciences ,
Motivation to Combine ,
Obviousness ,
Patent Applications ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents